Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Pulm Pharmacol Ther. 2017 May 5;45:80–89. doi: 10.1016/j.pupt.2017.05.003

Figure 2. iNKT cells in lungs and spleen.

Figure 2

Mice were treated i.p. with NKT-14, IgG2a (control Ab) or no treatment and then sensitized with HDM. Lungs and spleens were harvested and processed for flow cytometry. NKT-14 significantly reduced the iNKT in both lung and spleen. *p<0.05, **p<0.01.